FDA
approval
· 2025-04-02
FDA Approved: ORACEA — Supplemental Application (Galderma Laboratories, L.P.)
Summary
The FDA approves a supplemental application for ORACEA (doxycycline) from Galderma Laboratories, L.P.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ORACEA (DOXYCYCLINE)